首頁 > 市場調查報告書 > 製藥

消化器

全球制酸劑市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測

市場調查報告書

商品編碼

1306975

全球制酸劑市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測

Global Antacids Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年06月01日 | 出版商:

Value Market Research | 英文 141 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到2030年，全球制酸劑市場需求將從2022年的76.8億美元成長至106.8億美元，2023-2030年複合年成長率為4.21%。

制酸劑是用於緩解或預防胃酸過多相關症狀的藥物，如胃灼熱、消化不良、胃酸倒流和胃潰瘍。這些藥物透過中和胃酸發揮作用，有助於減輕胃酸過多引起的不適和灼燒感。

市場動態：

胃食道逆流病、消化性潰瘍和消化不良等胃腸道疾病越來越普遍，導致對抗酸藥的需求增加。這些疾病會導致胃酸分泌過多，出現胃灼熱和胃酸逆流等症狀，產生了對此類藥物的需求，以緩解不適症狀。現代生活方式，包括不規律的飲食模式、食用辛辣和油膩食物以及高度緊張，都會導致胃酸分泌增加，增加對這些藥物的需求。全球老年人口不斷增加，他們更容易患胃腸道疾病，是制酸劑的重要消費群體。消費者對胃腸道疾病認知的提高以及非處方藥的可獲得性推動了胃腸道疾病的市場需求，導致消費者傾向於自行用藥。壓力、久坐不動的生活方式和某些職業也會導致胃腸道症狀和對制酸劑的需求。醫療保健支出的總體成長和醫療保健服務的可及性導致越來越多的人因胃腸道症狀尋求醫療建議和治療。醫療保健專業人員通常建議將制酸劑作為控制輕度至中度症狀的初步選擇，進一步推動了需求。

研究涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰了解行業結構，評估全球競爭吸引力。此外，這些工具還對全球制酸劑市場的各個細分市場進行了全面評估。制酸劑行業的成長和趨勢為本研究提供了整體方法。

區域分析：

這部分涵蓋了區域前景，突出了北美、歐洲、亞太、拉丁美洲以及中東和非洲地區制酸劑市場的當前和未來需求。此外，這部分還重點分析了所有主要地區各個應用領域的需求、估計和預測。

本研究還涵蓋了市場中主要企業的綜合概況以及全球競爭格局的深入分析。制酸劑市場的主要企業包括GlaxoSmithKline plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., Sanofi, Reckitt Benckiser Group plc, Sun Pharmaceuticals Ltd., Takeda Pharmaceutical Company Limited, Pfizer Inc., Procter & Gamble。本部分包括競爭格局的整體視圖，其中包括各種戰略發展，如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

如果您有任何客製化要求，請聯繫我們。我們的研究團隊可以根據您的需求提供客製化服務。

地區前景
地區介紹
北美銷售分析
- 概述、歷史和預測資料銷售分析
- 北美細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測資料銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測資料銷售分析
- 亞太地區細分市場銷售分析
- 亞太地區各國銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 亞太其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測資料銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測資料銷售分析
- 中東及非洲各細分市場銷售分析
- 中東及非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第8章: 制酸劑企業競爭格局

制酸劑市場競爭
夥伴關係/合作/協議
合併與收購
新產品上市
其他發展

第9章: 公司概況

頂級公司市場佔有率分析
市場集中度
GlaxoSmithKline plc
- 公司概況
- 公司收入
- 產品
- 近期發展
Bayer AG
- 公司概況
- 公司收入
- 產品
- 近期發展
Boehringer Ingelheim International GmbH
- 公司概況
- 公司收入
- 產品
- 近期發展
Dr. Reddy's Laboratories Ltd.
- 公司概況
- 公司收入
- 產品
- 近期發展
Sanofi
- 公司概況
- 公司收入
- 產品
- 近期發展
Reckitt Benckiser Group plc
- 公司概況
- 公司收入
- 產品
- 近期發展
Sun Pharmaceuticals Ltd.
- 公司概況
- 公司收入
- 產品
- 近期發展
Takeda Pharmaceutical Company Limited
- 公司概況
- 公司收入
- 產品
- 近期發展
Pfizer Inc.
- 公司概況
- 公司收入
- 產品
- 近期發展
Procter & Gamble
- 公司概況
- 公司收入
- 產品
- 近期發展

注-在公司概況中，財務細節和近期發展視情況而定，如果是私營公司則可能不包括在內。

簡介目錄圖表

Product Code: VMR112111296

The global demand for Antacids Market is presumed to reach the market size of nearly USD 10.68 BN by 2030 from USD 7.68 BN in 2022 with a CAGR of 4.21% under the study period 2023 - 2030.

Antacids are medicines used to relieve or prevent symptoms associated with excessive stomach acids, such as heartburn, indigestion, acid reflux, and stomach ulcers. These medication work by neutralizing the acid in the stomach, which helps to reduce the discomfort and burning sensation caused by the excess acid.

MARKET DYNAMICS:

Gastrointestinal disorders such as GERD, peptic ulcers, and dyspepsia are becoming increasingly prevalent, leading to a higher need for antacids. These conditions result in excessive stomach acid production and symptoms like heartburn and acid reflux, creating a demand for these drugs to alleviate discomfort. Modern lifestyles, including irregular eating patterns, consumption of spicy and fatty foods, and high levels of stress, contribute to increased gastric acid production and the need for these medicines. The growing global geriatric population, who are more prone to gastrointestinal disorders, is a significant consumer group for antacids. The market demand for gastrointestinal disorders is driven by increased consumer awareness of these conditions and the availability of over-the-counter medicines, leading to a preference for self-medication. Stress, sedentary lifestyles, and certain occupations also contribute to gastrointestinal symptoms and the need for antacids. The overall increase in healthcare expenditure and accessibility to healthcare services has resulted in more individuals seeking medical advice and treatment for gastrointestinal symptoms. Healthcare professionals often recommend it as an initial option for managing mild to moderate symptoms, further driving the demand.

The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of antacids. The growth and trends of antacids industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the antacids market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Dosage Form

Tablet
Liquid
Others

By Distribution Channel

Retail Pharmacy
Hospital Pharmacy
Online Pharmacy

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Antacids market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the antacids market include GlaxoSmithKline plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., Sanofi, Reckitt Benckiser Group plc, Sun Pharmaceuticals Ltd., Takeda Pharmaceutical Company Limited, Pfizer Inc., Procter & Gamble. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.

1 . PREFACE

1.1. Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . ANTACIDS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Dosage Form
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ANTACIDS MARKET ANALYSIS BY DOSAGE FORM

5.1 Overview by Dosage Form
5.2 Historical and Forecast Data
5.3 Analysis by Dosage Form
5.4 Tablet Historic and Forecast Sales by Regions
5.5 Liquid Historic and Forecast Sales by Regions
5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL ANTACIDS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

6.1 Overview by Distribution Channel
6.2 Historical and Forecast Data
6.3 Analysis by Distribution Channel
6.4 Retail Pharmacy Historic and Forecast Sales by Regions
6.5 Hospital Pharmacy Historic and Forecast Sales by Regions
6.6 Online Pharmacy Historic and Forecast Sales by Regions

7 . GLOBAL ANTACIDS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Data Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Data Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Data Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Data Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Data Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE ANTACIDS COMPANIES

8.1. Antacids Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9 . COMPANY PROFILES OF ANTACIDS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. GlaxoSmithKline plc
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
9.4. Bayer AG
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
9.5. Boehringer Ingelheim International GmbH
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
9.6. Dr. Reddy's Laboratories Ltd.
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
9.7. Sanofi
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
9.8. Reckitt Benckiser Group plc
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments
9.9. Sun Pharmaceuticals Ltd.
- 9.9.1. Company Overview
- 9.9.2. Company Revenue
- 9.9.3. Products
- 9.9.4. Recent Developments
9.10. Takeda Pharmaceutical Company Limited
- 9.10.1. Company Overview
- 9.10.2. Company Revenue
- 9.10.3. Products
- 9.10.4. Recent Developments
9.11. Pfizer Inc.
- 9.11.1. Company Overview
- 9.11.2. Company Revenue
- 9.11.3. Products
- 9.11.4. Recent Developments
9.12. Procter & Gamble
- 9.12.1. Company Overview
- 9.12.2. Company Revenue
- 9.12.3. Products
- 9.12.4. Recent Developments